-20C, 1 month (sealed storage, away from moisture) Solvent & Solubility In Vitro : DMSO : 50 mg/mL (Need ultrasonic
We propose that hepatic activation of TH signaling has insulinotropic and glucose-lowering effects, as it is able to increase non-12-OH FXR-antagonistic BA levels through shaping the BA composition by repressing hepatic CYP8B1, thereby enhancing the GLP-1 production via suppressing intestinal FXR signaling
Available online: [Google Scholar] 13.Zhou X.-D., Chen Q.-F., Yang W., Zuluaga M., Targher G., Byrne C.D., Valenti L., Luo F., Katsouras C.S., Thaher O., et al
Treatment options The following list of medications are related to or used in the treatment of this condition